Navigation Links
FASEB announces the 2011 Summer Research Conference series: Registration is now open
Date:2/17/2011

Bethesda, MD - Since 1982, the FASEB SRC's have offered a continuing series of inter-disciplinary exchanges that are recognized as a valuable complement to the highly successful society meetings. Divided into small groups, scientists from around the world meet intimately and without distractions to explore new approaches to those research areas undergoing rapid scientific changes.

FASEB has announced 37 SRCs planned for the summer of 2011. Series topics include:

  • Microbial Polysaccharides of Medical, Agricultural, & Industrial Importance
  • Regulation & Function of Small GTPases
  • Proteases in Hemostasis & Vascular Biology
  • From Unfolded Proteins in the Endoplasmic Reticulum to Disease
  • The Molecular & Cellular Origins & the Biomedical Consequences of Protein Aggregation
  • Ion Channel Regulation
  • Biology & Chemistry of Vision
  • Mechanism & Regulation of Procaryotic Transcription
  • Signal Transduction in the Immune System
  • Molecular, Structural & Clinical Aspects of Vitamin K & Vitamin K Dependent Proteins
  • Polycystic Kidney Disease: From Bench to Bedside
  • Melatonin Receptors: Actions & Therapeutics
  • Histone Deacetylases & Reversible Acetylation in Signaling & Disease
  • Nutritional Immunology: Role in Health & Disease
  • Autoimmunity
  • Ciliate Molecular Biology
  • Molecular Mechanisms of Immune Cell Development & Function
  • Dynamic Regulation of Membrane-Based Processes by Tetraspanins & Other Scaffold Proteins
  • Protein Kinases & Protein Phosphorylation
  • Mitochondrial Assembly & Dynamics in Health, Disease & Aging
  • Probiotics, Intestinal Microbiota & the Host: Physiological & Clinical Implications
  • Protein Lipidation, Signaling, & Membrane Domains
  • Microbial Pathogenesis: Mechanisms of Infectious Disease
  • Genetic Recombination & Genome Rearrangements
  • Translational Neuroimmunology: From Mechanisms to Therapeutics
  • Hematopoietic Malignancies
  • Epigenetics, Chromatin & Transcription
  • Helicases & Nucleic Acid Translocases: Stucture, Mechanism, Function, & Roles in Human Diseases
  • Intracellular RNA Transport & Localized Translation (An EMBO, FASEB sponsored conference)
  • Mobile DNA in Mammalian Genomes
  • Nutrient Control of Metabolism & Cell Signaling
  • Lysophospholipid Mediators in Health & Disease
  • Glucose Transporters, Signaling, & Diabetes
  • Gastrointestinal Tract XIV: Stem Cells, Adaptation, Inflammation & Cancer
  • The TGF- Superfamily: Signaling in Development & Diseases
  • NAD Metabolism & Signaling
  • Transcriptional Elongation in Health & Disease

And new in 2011, FASEB has created individual event pages on Facebook and LinkedIn to help facilitate online collaboration prior to the meeting and beyond. This way, attendees can continue intimate discussions on these specialized topics even after the conference has ended. A listing of these event pages can be found at www.FASEB.org/SRC.


'/>"/>

Contact: Julie Levin
SRC@FASEB.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Related biology news :

1. FASEB Scientists Descend on Capitol Hill to Advocate for Increased Science Funding
2. FASEB Scientists Descend on Capitol Hill to Advocate for Increased Science Funding
3. FASEB alert generates messages urging Congress to provide billion dollar increase for NIH
4. FASEB praises President Obama for increasing funding for research in his FY 2012 budget
5. NIAID announces 25 new awards to develop radiation countermeasures
6. Aware Announces Q3 2008 Earnings Conference Call
7. Governor Doyle announces historic genomic research collaboration
8. BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders
9. NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders
10. Parkinsons Disease Foundation announces award of $150,000
11. Jefferson Department of Surgery announces new pancreas tumor registry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... India , April 13, 2017 According to ... Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, ... MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 Billion ... Growth Rate (CAGR) of 17.3%. ... MarketsandMarkets ...
(Date:4/6/2017)... April 6, 2017 Forecasts by ... Document Readers, by End-Use (Transportation & Logistics, Government & ... Gas & Fossil Generation Facility, Nuclear Power), Industrial, Retail, ... Are you looking for a definitive report ... ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces expanded coverage of ... newest module, US Hemostats & Sealants. , SmartTRAK’s US Market for Hemostats and ... synthetic sealants and biologic sealants used in surgical applications. BioMedGPS estimates the market ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... its endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression ... guides is transformative for performing systematic gain-of-function studies. , This complement to ...
(Date:10/11/2017)... , Oct. 11, 2017  VMS BioMarketing, a leading provider ... nationwide oncology Clinical Nurse Educator (CNE) network, which will launch ... for communication among health care professionals to enhance the patient ... office staff, and other health care professionals to help women ... cancer. ...
(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...
Breaking Biology Technology: